SG's Hummingbird Bioscience secures more capital in Series B extension round

SG's Hummingbird Bioscience secures more capital in Series B extension round

Antibody visual sourced from Hummingbird's website

Amid a pandemic-induced funding drought, private equity and venture capital firm Heritas Capital has stumped up extra funding for one of its deep tech startups.